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Purpose of study
Adults initiating ART in low-income countries have
higher mortality in the first 3 months on ART than
those in high-income countries, with more similar mor-
tality risks after 6 months. However, the specific pattern
of changing mortality risk after ART has not been inves-
tigated. It is also not known whether children initiating
ART are at the same high risk of early mortality as
adults in resource-limited settings.
Methods
We used flexible parametric proportional hazards mod-
els to investigate how the risks of death vary over the
first year on ART in adults (18+ years) from the DART
trial and children (6 months-15 years) from the
ARROW trial. We then estimated survival after ART
initiation according to pre-ART CD4/CD4% and investi-
gated the impact of age, sex and CD4/CD4% in multi-
variable models.
Results
Similar changes in early mortality were observed in both
adults and children. At all CD4/CD4%, mortality risk
increased from enrolment to a maximum between days
30-45, then declined rapidly to day 180, then declining
more slowly throughout the rest of the first year on
ART. Estimated mortality 14, 30, 90, 180 and 365 days
after ART initiation is shown in Table 1
Pooling data across adults and children, after adjusting
for CD4/CD4% group there was no evidence of an
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Table 1
DART DART DART DART ARROW ARROW ARROW ARROW ARROW ARROW
Age (years) 18+ 18+ 18+ 18+ 4-15 4-15 4-15 0-3 0-3 0-3
pre-ART CD4/CD4% 0-49 50-99 100-149 150-199 0-49 50-99 100+ 0-4% 5-9% 10%+
N 1106 784 759 661 131 56 552 27 87 348
Deaths in 1st year 103 36 23 17 14 2 7 2 4 9
Days after ART Estimated cumulative mortality
14 0.4% 0.1% 0.1% 0.1% 0.5% 0.1% 0.0% 0.4% 0.1% 0.1%
30 1.5% 0.6% 0.3% 0.3% 1.7% 0.5% 0.1% 1.5% 0.6% 0.3%
90 4.9% 2.1% 1.4% 1.1% 5.9% 2.3% 0.6% 5.2% 2.4% 1.3%
180 7.2% 3.4% 2.3% 1.8% 8.3% 3.5% 1.0% 7.4% 3.6% 2.0%
365 9.4% 4.5% 3.2% 2.5% 10.1% 4.5% 1.3% 9.1% 4.6% 2.6%
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any medium, provided the original work is properly cited.impact of age (p=0.29) or sex (p=0.17) on mortality dur-
ing the first year on ART. There was also no evidence
of a difference in mortality risk between those 4+ years
with CD4<50 cells/mm3 and 0-3 with CD4%<5%
(p=0.68), those 4+ years with CD4 50-99 and 0-3 with
CD4% 5-<10% (p=0.48) or those 4+ years with CD4 100
+ and 0-3 with CD4% 10%+ (p=0.24).
Conclusions
Children do not have significantly poorer survival on
ART than adults. However, children aged 4 years and
over and adults with low CD4 have remarkably similar,
and high, risks of mortality in the first 3 months after
ART initiation compared to those with higher CD4.
Children under 4 years with low CD4% are also at simi-
lar higher mortality risks.
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